Lilly Endowment Inc ownership in 1LLY / Eli Lilly and Company

Eli Lilly and Company

IT ˙ BIT ˙ US5324571083

979,80 € ↑43,70 (4,67%)

2026-06-04
CENA AKCJI

Security	IT:1LLY / Eli Lilly and Company
Institution	Lilly Endowment Inc
Latest Disclosed Ownership	92,190,516 shares
Ownership	9.80%

2026-01-23 - Lilly Endowment Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 92,190,516 shares of Eli Lilly and Company (IT:1LLY). This represents 9.8 percent ownership of the company. In their previous filing dated 2025-10-30 , Lilly Endowment Inc had reported owning 95,492,993 shares, indicating a decrease of -3.46 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2026-01-23	2026-01-23	13G/A	95,492,993	92,190,516	-3.46	9.80	-2.97
2025-10-30	2025-10-30	13G/A	96,016,978	95,492,993	-0.55	10.10	0.00
2025-04-16	2025-04-16	13G/A	96,891,978	96,016,978	-0.90	10.10	-0.98
2025-01-27	2025-01-27	13G/A	99,768,810	96,891,978	-2.88	10.20	-2.95
2024-01-26	2024-01-26	13G/A	102,948,810	99,768,810	-3.09	10.51	-2.95
2023-01-25	2023-01-25	13G/A	107,463,810	102,948,810	-4.20	10.83	-3.56
2022-01-27	2022-01-27	13G/A	111,132,343	107,463,810	-3.30	11.23	-3.36
2021-01-21	2021-01-21	13G/A	144,560,599	111,132,343	-23.12	11.62	-2.35
2020-01-14	2020-01-14	13G/A	118,015,304	144,560,599	22.49	11.90	7.21
2019-01-14	2019-01-14	13G/A	123,075,804	118,015,304	-4.11	11.10	-0.89
2018-01-17	2018-01-17	13G/A	125,575,804	123,075,804	-1.99	11.20	-1.75
2017-01-13	2017-01-13	13G/A	127,860,804	125,575,804	-1.79	11.40	-0.87
2016-01-12	2016-01-12	13G/A		127,860,804		11.50
2015-01-21	2015-01-21	13G/A		131,405,804		11.80

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-20	2026-03-31	13F	Eli Lilly and	Common	532457108	91,896,978	-293,538	-0.32	84,524,083	-14.69	100.0000
2026-01-23	2025-12-31	13F	Eli Lilly and	Common	532457108	92,190,516	-3,302,477	-3.46	99,075,304	35.98	100.0000
2025-10-31	2025-09-30	13F	Eli Lilly and	Common	532457108	95,492,993	-523,985	-0.55	72,861,154	-2.65	100.0000
2025-07-10	2025-06-30	13F	Eli Lilly and	Common	532457108	96,016,978	0	0.00	74,848,115	-5.62	100.0000
2025-04-16	2025-03-31	13F	Eli Lilly and	Common	532457108	96,016,978	-875,000	-0.90	79,301,382	6.02	100.0000
2025-01-27	2024-12-31	13F	Eli Lilly and	Common	532457108	96,891,978	0	0.00	74,800,607	-12.86	100.0000
2024-10-03	2024-09-30	13F	Eli Lilly and	Common	532457108	96,891,978	-475,391	-0.49	85,840,479	-2.62	100.0000
2024-07-16	2024-06-30	13F	Eli Lilly and	Common	532457108	97,367,369	-1,531,441	-1.55	88,154,469	14.58	100.0000
2024-04-16	2024-03-31	13F	Eli Lilly and	Common	532457108	98,898,810	-870,000	-0.87	76,939,318	32.30	100.0000
2024-01-25	2023-12-31	13F	Eli Lilly and	Common	532457108	99,768,810	-215,000	-0.22	58,157,235	8.29	100.0000
2023-10-12	2023-09-30	13F	Eli Lilly and	Common	532457108	99,983,810	-1,045,000	-1.03	53,704,304	13.35	100.0000
2023-07-10	2023-06-30	13F	Eli Lilly and	Common	532457108	101,028,810	-1,515,000	-1.48	47,380,491	34.54	100.0000
2023-04-17	2023-03-31	13F	Eli Lilly and	Common	532457108	102,543,810	-405,000	-0.39	35,215,595	-6.50	100.0000
2023-01-26	2022-12-31	13F	Eli Lilly and	Common	532457108	102,948,810	-825,000	-0.79	37,662,793	12.24	100.0000
2022-10-05	2022-09-30	13F	Eli Lilly and	Common	532457108	103,773,810	-387,243	-0.37	33,555,261	-0.64	100.0000
2022-07-18	2022-06-30	13F	Eli Lilly and	Common	532457108	104,161,053	-1,993,133	-1.88	33,772,138	11.09	100.0000
2022-04-19	2022-03-31	13F	Eli Lilly and	Common	532457108	106,154,186	-1,309,624	-1.22	30,399,374	2.41	100.0000
2022-01-27	2021-12-31	13F	Eli Lilly and	Common	532457108	107,463,810	-784,800	-0.72	29,683,654	18.68	100.0000
2021-10-08	2021-09-30	13F	Eli Lilly and	Common	532457108	108,248,610	-1,150,592	-1.05	25,010,841	-0.39	100.0000
2021-07-19	2021-06-30	13F	Eli Lilly and	Common	532457108	109,399,202	-902,898	-0.82	25,109,305	21.85	100.0000
2021-04-12	2021-03-31	13F	Eli Lilly and	Common	532457108	110,302,100	-830,243	-0.75	20,606,638	9.82	100.0000
2021-01-21	2020-12-31	13F	Eli Lilly and	Common	532457108	111,132,343	0	0.00	18,763,585	14.07	100.0000
2020-10-05	2020-09-30	13F	Eli Lilly and	Common	532457108	111,132,343	-427,961	-0.38	16,449,809	-10.19	100.0000
2020-07-16	2020-06-30	13F	Eli Lilly and	Common	532457108	111,560,304	-1,711,038	-1.51	18,315,971	16.57	100.0000
2020-04-10	2020-03-31	13F	Eli Lilly and	Common	532457108	113,271,342	-1,289,257	-1.13	15,713,001	4.36	100.0000
2020-01-13	2019-12-31	13F	Eli Lilly and	Common	532457108	114,560,599	-2,039,705	-1.75	15,056,699	15.47	100.0000
2019-10-08	2019-09-30	13F	Eli Lilly and	Common	532457108	116,600,304	-210,000	-0.18	13,039,412	0.76	100.0000
2019-07-15	2019-06-30	13F	Eli Lilly and	Common	532457108	116,810,304	0	0.00	12,941,414	-14.62	100.0000
2019-04-16	2019-03-31	13F	Eli Lilly and	Common	532457108	116,810,304	-1,205,000	-1.02	15,157,305	10.99	100.0000
2019-01-14	2018-12-31	13F	Eli Lilly and	Common	532457108	118,015,304	-1,385,500	-1.16	13,656,731	6.59	100.0000
2018-10-09	2018-09-30	13F	Eli Lilly and	Common	532457108	119,400,804	-2,650,000	-2.17	12,812,900	23.03	100.0000
2018-07-12	2018-06-30	13F	Eli Lilly and	Common	532457108	122,050,804	-1,025,000	-0.83	10,414,595	9.37	100.0000
2018-04-10	2018-03-31	13F	Eli Lilly and	Common	532457108	123,075,804	0	0.00	9,522,375	-8.39	100.0000
2018-01-17	2017-12-31	13F	Eli Lilly and	Common	532457108	123,075,804	-405,000	-0.33	10,394,982	-1.59	100.0000
2017-10-10	2017-09-30	13F	Eli Lilly and	Common	532457108	123,480,804	-785,000	-0.63	10,562,548	3.28	100.0000
2017-07-13	2017-06-30	13F	Eli Lilly and	Common	532457108	124,265,804	-425,000	-0.34	10,227,076	-2.49	100.0000
2017-04-14	2017-03-31	13F	Eli Lilly and	Common	532457108	124,690,804	-885,000	-0.70	10,487,744	13.55	100.0000
2017-01-13	2016-12-31	13F	Eli Lilly and	Common	532457108	125,575,804	-200,000	-0.16	9,236,100	-8.51	100.0000
2016-10-12	2016-09-30	13F	Eli Lilly and	Common	532457108	125,775,804	-880,000	-0.69	10,094,766	1.21	100.0000
2016-07-07	2016-06-30	13F	Eli Lilly and	Common	532457108	126,655,804	-1,205,000	-0.94	9,974,145	8.33	100.0000
2016-04-13	2016-03-31	13F	Eli Lilly and	Common	532457108	127,860,804	0	0.00	9,207,256	-14.54	100.0000
2016-01-12	2015-12-31	13F	Eli Lilly and	Common	532457108	127,860,804	-1,510,000	-1.17	10,773,551	-0.49	100.0000
2015-10-08	2015-09-30	13F	Eli Lilly and	Common	532457108	129,370,804	-250,000	-0.19	10,827,043	0.05	100.0000
2015-07-29	2015-06-30	13F	Eli Lilly and	Common	532457108	129,620,804	-1,415,000	-1.08	10,822,041	13.68	100.0000
2015-04-09	2015-03-31	13F	Eli Lilly and	Common	532457108	131,035,804	-370,000	-0.28	9,519,751	5.01	100.0000
2015-01-21	2014-12-31	13F	Eli Lilly and	Common	532457108	131,405,804	-1,325,000	-1.00	9,065,686	5.32	100.0000
2014-10-08	2014-09-30	13F	Eli Lilly and	Common	532457108	132,730,804	-1,095,000	-0.82	8,607,593	3.46	100.0000
2014-07-16	2014-06-30	13F	Eli Lilly and	Common	532457108	133,825,804	-1,845,000	-1.36	8,319,950	4.19	100.0000
2014-04-09	2014-03-31	13F	Eli Lilly and	Common	532457108	135,670,804	0	0.00	7,985,584	15.41	100.0000
2014-01-09	2013-12-31	13F	Eli Lilly and	Common	532457108	135,670,804	0	0.00	6,919,211	1.33	100.0000
2013-10-15	2013-09-30	13F	Eli Lilly and	Common	532457108	135,670,804	0	0.00	6,828,312	2.46	100.0000
2013-07-16	2013-06-30	13F	Eli Lilly and	Common	532457108	135,670,804	135,670,804		6,664,150		100.0000

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.